Investor profile
Oxford University Innovation Fund has backed 4 European tech companies across 5 funding rounds between 2018 and 2025, joining rounds totalling €131M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 1 | €90M |
| Brainomix | UK | 2 | €27M |
| Scripta Therapeutics | UK | 1 | €10M |
| DaltonTx | UK | 1 | €4.6M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Brainomix | Series B | €19M | 2021-12 |
| Scripta Therapeutics | Seed | €10M | 2025-11 |
| Brainomix |
| Other |
| €8.0M |
| 2018-02 |
| DaltonTx | Seed | €4.6M | 2025-09 |
